145 related articles for article (PubMed ID: 38165318)
1. Clinicopathologic Findings in Patients With Paraneoplastic Neuropathies and Antibodies Strongly Associated With Cancer.
Granger A; Rajnauth T; Lahoria R; Dubey D; Mills J; Mauermann ML; Berini SE; Spinner RJ; Dyck PJB; Klein CJ
Neurology; 2024 Jan; 102(2):e207982. PubMed ID: 38165318
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.
Shelly S; Dubey D; Mills JR; Klein CJ
Handb Clin Neurol; 2024; 200():239-273. PubMed ID: 38494281
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.
Shah S; Vazquez Do Campo R; Kumar N; McKeon A; Flanagan EP; Klein C; Pittock SJ; Dubey D
Neurology; 2021 Jan; 96(4):e632-e639. PubMed ID: 33208548
[TBL] [Abstract][Full Text] [Related]
4. Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.
Dubey D; Jitprapaikulsan J; Bi H; Do Campo RV; McKeon A; Pittock SJ; Engelstad JK; Mills JR; Klein CJ
Neurology; 2019 Nov; 93(20):e1873-e1880. PubMed ID: 31624089
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.
Camdessanché JP; Antoine JC; Honnorat J; Vial C; Petiot P; Convers P; Michel D
Brain; 2002 Jan; 125(Pt 1):166-75. PubMed ID: 11834602
[TBL] [Abstract][Full Text] [Related]
6. Dorsal cauda equina nerve root enhancement on magnetic resonance imaging due to ANNA-1-associated paraneoplastic polyneuropathy.
Madhavan AA; Guerin JB; Eckel LJ; Lehman VT; Carr CM
Neuroradiol J; 2020 Oct; 33(5):443-447. PubMed ID: 32290766
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic neuropathies].
Mallecourt C; Delattre JY
Presse Med; 2000 Mar; 29(8):447-52. PubMed ID: 10738514
[TBL] [Abstract][Full Text] [Related]
8. Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features.
Waheed W; Boyd J; Khan F; Mount SL; Borden NM; Tandan R
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27571910
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations.
Koike H; Tanaka F; Sobue G
Curr Opin Neurol; 2011 Oct; 24(5):504-10. PubMed ID: 21799410
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic neuropathy.
Koike H; Sobue G
Handb Clin Neurol; 2013; 115():713-26. PubMed ID: 23931811
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibodies define a subgroup of paraneoplastic neuropathies: clinical and immunological data.
Tschernatsch M; Stolz E; Strittmatter M; Kaps M; Blaes F
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1702-6. PubMed ID: 16291897
[TBL] [Abstract][Full Text] [Related]
12. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
Jarius S; Ringelstein M; Haas J; Serysheva II; Komorowski L; Fechner K; Wandinger KP; Albrecht P; Hefter H; Moser A; Neuen-Jacob E; Hartung HP; Wildemann B; Aktas O
J Neuroinflammation; 2016 Oct; 13(1):278. PubMed ID: 27776522
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic neuropathies.
Antoine JC; Camdessanché JP
Curr Opin Neurol; 2017 Oct; 30(5):513-520. PubMed ID: 28682959
[TBL] [Abstract][Full Text] [Related]
14. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.
Pittock SJ; Lucchinetti CF; Lennon VA
Ann Neurol; 2003 May; 53(5):580-7. PubMed ID: 12730991
[TBL] [Abstract][Full Text] [Related]
15. Ataxic vs painful form of paraneoplastic neuropathy.
Oki Y; Koike H; Iijima M; Mori K; Hattori N; Katsuno M; Nakamura T; Hirayama M; Tanaka F; Shiraishi M; Yazaki S; Nokura K; Yamamoto H; Sobue G
Neurology; 2007 Aug; 69(6):564-72. PubMed ID: 17679675
[TBL] [Abstract][Full Text] [Related]
16. Orthostatic hypotension secondary to CRMP-5 paraneoplastic autonomic neuropathy.
Neal AJ; Qian MY; Clinch AS; Le BH
J Clin Neurosci; 2014 May; 21(5):885-6. PubMed ID: 24268757
[TBL] [Abstract][Full Text] [Related]
17. Treatment for paraneoplastic neuropathies.
Giometto B; Vitaliani R; Lindeck-Pozza E; Grisold W; Vedeler C
Cochrane Database Syst Rev; 2012 Dec; 12():CD007625. PubMed ID: 23235647
[TBL] [Abstract][Full Text] [Related]
18. Serum and Cerebrospinal Fluid Testing in Optic Neuropathy Patients with Malignant Tumors.
Sun CB; Liu GH; Xiao Q; Zhao YN; Ren Q
Dis Markers; 2022; 2022():7076385. PubMed ID: 35222744
[TBL] [Abstract][Full Text] [Related]
19. [Paraneoplastic peripheral neuropathies].
Antoine JC; Camdessanche JP
Rev Neurol (Paris); 2004 Feb; 160(2):188-98. PubMed ID: 15034476
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy.
Antoine JC; Honnorat J; Camdessanché JP; Magistris M; Absi L; Mosnier JF; Petiot P; Kopp N; Michel D
Ann Neurol; 2001 Feb; 49(2):214-21. PubMed ID: 11220741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
